ATE273299T1 - Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung - Google Patents

Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung

Info

Publication number
ATE273299T1
ATE273299T1 AT98928886T AT98928886T ATE273299T1 AT E273299 T1 ATE273299 T1 AT E273299T1 AT 98928886 T AT98928886 T AT 98928886T AT 98928886 T AT98928886 T AT 98928886T AT E273299 T1 ATE273299 T1 AT E273299T1
Authority
AT
Austria
Prior art keywords
benzpyrido
cycloheptan
derivatives
inhibiting effect
protein transferase
Prior art date
Application number
AT98928886T
Other languages
English (en)
Inventor
Alan B Cooper
Ronald J Doll
Viyyoor M Girijavallabhan
Ashit Ganguly
John C Reader
John J Baldwin
Chia-Yu Huang
Original Assignee
Schering Corp
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Pharmacopeia Inc filed Critical Schering Corp
Application granted granted Critical
Publication of ATE273299T1 publication Critical patent/ATE273299T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98928886T 1997-06-17 1998-06-15 Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung ATE273299T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87774197A 1997-06-17 1997-06-17
PCT/US1998/011495 WO1998057960A1 (en) 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase

Publications (1)

Publication Number Publication Date
ATE273299T1 true ATE273299T1 (de) 2004-08-15

Family

ID=25370618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928886T ATE273299T1 (de) 1997-06-17 1998-06-15 Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung

Country Status (18)

Country Link
EP (1) EP0989983B1 (de)
JP (1) JP2002504144A (de)
KR (1) KR100640672B1 (de)
CN (1) CN1266433A (de)
AR (1) AR012991A1 (de)
AT (1) ATE273299T1 (de)
AU (1) AU753658B2 (de)
CA (1) CA2293714C (de)
DE (1) DE69825589T2 (de)
ES (1) ES2224408T3 (de)
HU (1) HUP0003138A3 (de)
IL (2) IL133386A0 (de)
MY (1) MY143570A (de)
NZ (1) NZ501376A (de)
PE (1) PE104798A1 (de)
TW (1) TW587935B (de)
WO (1) WO1998057960A1 (de)
ZA (1) ZA985203B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776558B2 (en) 1998-12-18 2004-09-16 Schering Corporation Tricyclic farnesyl protein transferase inhibitors
US6800636B2 (en) 1998-12-18 2004-10-05 Schering Corporation Farnesyl protein transferase inhibitors
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
BR9916328A (pt) * 1998-12-18 2001-10-02 Schering Corp Inibidores de transferase de farnesila
US6432959B1 (en) * 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
AU2002236813A1 (en) 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002080895A2 (en) * 2001-04-06 2002-10-17 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
JP4713152B2 (ja) * 2002-09-20 2011-06-29 メルク セローノ ソシエテ アノニム ピペラジン誘導体及び使用方法
JP2008523104A (ja) 2004-12-13 2008-07-03 シェーリング コーポレイション 癌を治療するための新規なファルネシルタンパク質トランスフェラーゼ阻害剤およびその使用
CA2591123A1 (en) * 2004-12-14 2006-06-22 Schering Corporation Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
PT2807153T (pt) * 2012-01-25 2020-06-18 Novartis Ag Compostos heterocíclicos e métodos para seu uso
EP3541375B1 (de) * 2016-11-18 2023-08-23 Merck Sharp & Dohme LLC Faktor xiia inhibitoren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76066A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases, pharmaceutical compositions containing them and process for producing them
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
TW587935B (en) 2004-05-21
CN1266433A (zh) 2000-09-13
MY143570A (en) 2011-05-31
DE69825589T2 (de) 2005-09-08
HUP0003138A3 (en) 2002-11-28
AU8058098A (en) 1999-01-04
WO1998057960A1 (en) 1998-12-23
IL133386A0 (en) 2001-04-30
EP0989983A1 (de) 2000-04-05
EP0989983B1 (de) 2004-08-11
HUP0003138A2 (hu) 2001-06-28
PE104798A1 (es) 1999-11-06
ES2224408T3 (es) 2005-03-01
CA2293714C (en) 2009-09-08
JP2002504144A (ja) 2002-02-05
KR20010013822A (ko) 2001-02-26
CA2293714A1 (en) 1998-12-23
ZA985203B (en) 1999-01-05
DE69825589D1 (de) 2004-09-16
AU753658B2 (en) 2002-10-24
NZ501376A (en) 2002-03-28
IL133386A (en) 2006-12-10
AR012991A1 (es) 2000-11-22
KR100640672B1 (ko) 2006-11-02

Similar Documents

Publication Publication Date Title
EE04309B1 (et) Farnesüül-proteiini transferaasi inhibiitorid
EE9800408A (et) Proteiinfarnesüültransferaasi inhibiitorid
IS4568A (is) Farnesýl-prótein transferasa latar
DK1162201T3 (da) Farnesylproteintransferaseinhiberende (imidazol-5-yl)methyl-2-quinolinonderivater
NO996571L (no) Inhibitorer for farnesyl-protein-transferase
DE59709582D1 (de) Hetaroylcyclohexandionderivate mit herbizider wirkung
FI952010A (fi) Farnesyyliproteiinitransferaasin estäjät
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
DE59710547D1 (de) Thienopyrimidine mit pde v inhibierender wirkung
DE69613367D1 (de) Chinazolin derivate
DE69706292D1 (de) Chinazoline derivate
DE69618999T2 (de) Farnesyltransferase hemmende 2-chinolonderivate
NO20024950L (no) 4-Merkaptopyrrolidinderivater som farnesyltransferaseinhibitorer
DE69924876D1 (de) Farnesyl protein transferase inhibitoren
ATE273299T1 (de) Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
DE69606165T2 (de) Bizyclische isothioharnstoff-derivate mit therapeutischer wirkung
DE69825608D1 (de) Benzo[5,6]cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
FI953170A (fi) Oligunokleotidit isoprenyyliproteiinitransferaasin ilmentämisen inhibiboimiseksi
DE69805974T2 (de) 5-aroylnaphthalin derivate
DK0948483T3 (da) Farnesyltransferaseinhibitorer
KR970000042A (ko) 육절기
FR2722499B1 (fr) Nouveaux derives de 2-imidazoline-5-ones fongicides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties